The Role of Virtual Data Rooms in Drug & Device Development
In biotech, the term "virtual data room" often conjures images of fundraising diligence: a static folder of key documents used to satisfy investors or legal teams during a transaction. But...
All About 21 CFR Part 11 Compliance
What is 21 CFR Part 11?
21 CFR Part 11 is a regulation established by the U.S. Food and Drug Administration (FDA) that sets the criteria for electronic records and electronic signatures...
The Future of eQMS: How Automation is Changing Compliance and Quality
As regulatory requirements become increasingly stringent in the pharmaceutical and medical device industries, companies must adopt efficient, scalable, and compliant solutions to manage...
What's Good in QC? Understanding Quality Control and Compliance Standards: GQC, GMP, GLP, GCP, and GDP
Maintaining high standards of quality and safety in life sciences industries is essential. Several globally recognized quality management systems have been established to ensure...
Toban Zolman joins Steve Gens to discuss Kivo's rapid growth
In this episode of the Gens & Associates Podcast, Kivo CEO Toban Zolman joins managing partner Steve Gens to discuss Kivo's success with smaller stage life science companies, Kivo's process...
Drug Development Trends for 2025 and Beyond
As we look ahead to 2025, there’s no doubt that we’re at a transformative moment in the life sciences industry. The pace of change is accelerating, driven by groundbreaking advancements in...
Podcast: Revolutionizing Drug Development: Toban Zolman's Journey
In this interview, Don Davis PhD, MBA, host of the Life Science Success Podcast talks to Kivo CEO Toban Zolman. Zolman takes us through his impressive journey of over 20 years in life...
Podcast: Running Regulatory and Clinical Operations in an AI world
Artificial intelligence tools are revolutionizing nearly every stage of the drug discovery process, offering substantial potential to reshape the speed and economics of the industry. As the...